pharma · Pain · Hyponatremia · CPIX
Cumberland Pharmaceuticals
CUMBERLAND PHARMACEUTICALS INC
Cumberland Pharmaceuticals clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1600 W End Ave, #1300, Nashville, Tennessee 37203, US
- Founded
- 1999
- Employees
- 128
- Programs
- 53
- Drugs
- 26
- Patents
- 34
Cumberland Pharmaceuticals projects
14 ClinicalTrials.gov programs sponsored by Cumberland Pharmaceuticals.
Cumberland Pharmaceuticals has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Conivaptan
CUMBERLAND PHARMACEUTICALS INC
Hyponatremia
4 trials -
IV Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Chronic Pelvic Pain
1 trial -
IV ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Arthroscopic Knee Surgery
1 trial -
IV ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Pain
1 trial -
Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Ductus Arteriosus, Patent
1 trial -
Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Pain
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Obesity
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Fever
1 trial -
Intravenous ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Pain
3 trials -
Ofirmev
CUMBERLAND PHARMACEUTICALS INC
Pain
1 trial -
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Cystic Fibrosis
1 trial -
Telavancin Injection
CUMBERLAND PHARMACEUTICALS INC
Subarachnoid Hemorrhage, Aneurysmal
1 trial -
intravenous NAC
CUMBERLAND PHARMACEUTICALS INC
Nephropathy
1 trial -
lactulose (Kristalose®)
CUMBERLAND PHARMACEUTICALS INC
Constipation
1 trial
Frequently asked questions
How many clinical projects does Cumberland Pharmaceuticals have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.